tiprankstipranks
Verrica Pharmaceuticals reports Q4 EPS (53c), consensus (53c)
PremiumThe FlyVerrica Pharmaceuticals reports Q4 EPS (53c), consensus (53c)
2M ago
Verrica Pharmaceuticals Announces Participation in the TD Cowen 44th Annual Healthcare Conference
PremiumPress Releases
Verrica Pharmaceuticals Announces Participation in the TD Cowen 44th Annual Healthcare Conference
2M ago
VRCA Earnings this Week: How Will it Perform?
PremiumPre-Earnings
VRCA Earnings this Week: How Will it Perform?
2M ago
Verrica Pharmaceuticals receives permanent J-Code for YCANTH from CMS
PremiumThe FlyVerrica Pharmaceuticals receives permanent J-Code for YCANTH from CMS
3M ago
Verrica Pharmaceuticals Announces Last Patient Dosed in Part 2 of Phase 2 Study of VP-315, a Potential First-in-Class Oncolytic Peptide-Based Immunotherapy, for the Treatment of Basal Cell Carcinoma
PremiumPress Releases
Verrica Pharmaceuticals Announces Last Patient Dosed in Part 2 of Phase 2 Study of VP-315, a Potential First-in-Class Oncolytic Peptide-Based Immunotherapy, for the Treatment of Basal Cell Carcinoma
4M ago
Verrica Pharmaceuticals announces last patient dosed in Phase 2 trial of VP-315
PremiumThe Fly
Verrica Pharmaceuticals announces last patient dosed in Phase 2 trial of VP-315
4M ago
Insider Trading: Verrica Stock (NASDAQ:VRCA) Gained on $6.9M Insider Buy
PremiumMarket NewsInsider Trading: Verrica Stock (NASDAQ:VRCA) Gained on $6.9M Insider Buy
4M ago
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
4M ago
Verrica Pharmaceuticals’ Development and Commercialization Partner, Torii Pharmaceutical Co., Ltd., Announces Positive Top-line Results from a Confirmatory Phase 3 Trial of TO-208 for the Treatment of Molluscum Contagiosum in Japan
PremiumPress Releases
Verrica Pharmaceuticals’ Development and Commercialization Partner, Torii Pharmaceutical Co., Ltd., Announces Positive Top-line Results from a Confirmatory Phase 3 Trial of TO-208 for the Treatment of Molluscum Contagiosum in Japan
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100